Jazz Pharmaceuticals
E874302
Jazz Pharmaceuticals is a biopharmaceutical company specializing in developing and commercializing innovative medicines for sleep disorders, oncology, and rare diseases.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Jazz Pharmaceuticals canonical | 3 |
| Jazz Pharmaceuticals, Inc. | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T10609879 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Jazz Pharmaceuticals Context triple: [Epidiolex, marketedBy, Jazz Pharmaceuticals]
-
A.
Janssen Pharmaceuticals
Janssen Pharmaceuticals is a global pharmaceutical company, part of Johnson & Johnson, known for developing and marketing a wide range of prescription medicines across areas such as immunology, oncology, neuroscience, and cardiovascular disease.
-
B.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
C.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
-
D.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
-
E.
Eisai
Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Jazz Pharmaceuticals Target entity description: Jazz Pharmaceuticals is a biopharmaceutical company specializing in developing and commercializing innovative medicines for sleep disorders, oncology, and rare diseases.
-
A.
Janssen Pharmaceuticals
Janssen Pharmaceuticals is a global pharmaceutical company, part of Johnson & Johnson, known for developing and marketing a wide range of prescription medicines across areas such as immunology, oncology, neuroscience, and cardiovascular disease.
-
B.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
C.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
-
D.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
-
E.
Eisai
Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
public company ⓘ |
| acquired | GW Pharmaceuticals ⓘ |
| country |
United States
ⓘ
linked to:
United States of America
|
| engagesIn |
clinical research
ⓘ
commercialization of therapies ⓘ drug development ⓘ |
| focusesOn |
oncology
ⓘ
rare diseases ⓘ sleep disorders ⓘ unmet medical needs ⓘ |
| foundedAs |
Jazz Pharmaceuticals, Inc.
ⓘ
linked to:
Jazz Pharmaceuticals
|
| hasKeyProductType |
orphan drugs
ⓘ
specialty pharmaceuticals ⓘ |
| hasProduct |
Defitelio
ⓘ
Epidiolex ⓘ Rylaze ⓘ Sunosi ⓘ Vyxeos ⓘ Xyrem ⓘ Xywav ⓘ Zepzelca ⓘ |
| hasSubsidiary | GW Pharmaceuticals ⓘ |
| hasTherapeuticArea |
hematology
ⓘ
oncology ⓘ rare diseases ⓘ sleep medicine ⓘ |
| hasTickerSymbol | JAZZ ⓘ |
| headquartersCountry | Ireland ⓘ |
| headquartersLocation | Dublin ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| listedOn | NASDAQ ⓘ |
| regulatoryApprovalFrom |
European Medicines Agency
ⓘ
U.S. Food and Drug Administration ⓘ
linked to:
Food and Drug Administration
|
| specializesIn |
commercializing medicines
ⓘ
developing medicines ⓘ |
| targetMarket | patients with serious diseases ⓘ |
| treatsCondition |
Dravet syndrome
ⓘ
Lennox–Gastaut syndrome ⓘ
linked to:
Lennox-Gastaut syndrome
acute lymphoblastic leukemia ⓘ acute myeloid leukemia ⓘ cataplexy ⓘ excessive daytime sleepiness ⓘ hepatic veno-occlusive disease ⓘ narcolepsy ⓘ small cell lung cancer ⓘ tuberous sclerosis complex–associated seizures ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Jazz Pharmaceuticals Description of subject: Jazz Pharmaceuticals is a biopharmaceutical company specializing in developing and commercializing innovative medicines for sleep disorders, oncology, and rare diseases.
Referenced by (4)
Full triples — surface form annotated when it differs from this entity's canonical label.
linked to: Jazz Pharmaceuticals